FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091917308> ?p ?o ?g. }

• W2091917308 endingPage "95" @default.
• W2091917308 startingPage "88" @default.
• W2091917308 abstract "The gene for cystathionine β-synthase (CBS) is located on chromosome 21 and is overexpressed in children with Down syndrome (DS), or trisomy 21. The dual purpose of the present study was to evaluate the impact of overexpression of the CBS gene on homocysteine metabolism in children with DS and to determine whether the supplementation of trisomy 21 lymphoblasts in vitro with selected nutrients would shift the genetically induced metabolic imbalance. Plasma samples were obtained from 42 children with karyotypically confirmed full trisomy 21 and from 36 normal siblings (mean age 7.4 years). Metabolites involved in homocysteine metabolism were measured and compared to those of normal siblings used as controls. Lymphocyte DNA methylation status was determined as a functional endpoint. The results indicated that plasma levels of homocysteine, methionine, S-adenosylhomocysteine, and S-adenosylmethionine were all significantly decreased in children with DS and that their lymphocyte DNA was hypermethylated relative to that in normal siblings. Plasma levels of cystathionine and cysteine were significantly increased, consistent with an increase in CBS activity. Plasma glutathione levels were significantly reduced in the children with DS and may reflect an increase in oxidative stress due to the overexpression of the superoxide dismutase gene, also located on chromosome 21. The addition of methionine, folinic acid, methyl-B12, thymidine, or dimethylglycine to the cultured trisomy 21 lymphoblastoid cells improved the metabolic profile in vitro. The increased activity of CBS in children with DS significantly alters homocysteine metabolism such that the folate-dependent resynthesis of methionine is compromised. The decreased availability of homocysteine promotes the well-established “folate trap,” creating a functional folate deficiency that may contribute to the metabolic pathology of this complex genetic disorder. The gene for cystathionine β-synthase (CBS) is located on chromosome 21 and is overexpressed in children with Down syndrome (DS), or trisomy 21. The dual purpose of the present study was to evaluate the impact of overexpression of the CBS gene on homocysteine metabolism in children with DS and to determine whether the supplementation of trisomy 21 lymphoblasts in vitro with selected nutrients would shift the genetically induced metabolic imbalance. Plasma samples were obtained from 42 children with karyotypically confirmed full trisomy 21 and from 36 normal siblings (mean age 7.4 years). Metabolites involved in homocysteine metabolism were measured and compared to those of normal siblings used as controls. Lymphocyte DNA methylation status was determined as a functional endpoint. The results indicated that plasma levels of homocysteine, methionine, S-adenosylhomocysteine, and S-adenosylmethionine were all significantly decreased in children with DS and that their lymphocyte DNA was hypermethylated relative to that in normal siblings. Plasma levels of cystathionine and cysteine were significantly increased, consistent with an increase in CBS activity. Plasma glutathione levels were significantly reduced in the children with DS and may reflect an increase in oxidative stress due to the overexpression of the superoxide dismutase gene, also located on chromosome 21. The addition of methionine, folinic acid, methyl-B12, thymidine, or dimethylglycine to the cultured trisomy 21 lymphoblastoid cells improved the metabolic profile in vitro. The increased activity of CBS in children with DS significantly alters homocysteine metabolism such that the folate-dependent resynthesis of methionine is compromised. The decreased availability of homocysteine promotes the well-established “folate trap,” creating a functional folate deficiency that may contribute to the metabolic pathology of this complex genetic disorder." @default.
• W2091917308 created "2016-06-24" @default.
• W2091917308 creator A5001010319 @default.
• W2091917308 creator A5024927199 @default.
• W2091917308 creator A5037379883 @default.
• W2091917308 creator A5062637673 @default.
• W2091917308 creator A5080241543 @default.
• W2091917308 creator A5090458735 @default.
• W2091917308 date "2001-07-01" @default.
• W2091917308 modified "2023-10-16" @default.
• W2091917308 title "Homocysteine Metabolism in Children with Down Syndrome: In Vitro Modulation" @default.
• W2091917308 cites W1484723238 @default.
• W2091917308 cites W1891735186 @default.
• W2091917308 cites W1917426361 @default.
• W2091917308 cites W1943432788 @default.
• W2091917308 cites W1970822344 @default.
• W2091917308 cites W1988901034 @default.
• W2091917308 cites W1989312655 @default.
• W2091917308 cites W2004824056 @default.
• W2091917308 cites W2008403704 @default.
• W2091917308 cites W2018319609 @default.
• W2091917308 cites W2023546803 @default.
• W2091917308 cites W2027036934 @default.
• W2091917308 cites W2032420850 @default.
• W2091917308 cites W2040904496 @default.
• W2091917308 cites W2042094189 @default.
• W2091917308 cites W2049292893 @default.
• W2091917308 cites W2059123635 @default.
• W2091917308 cites W2069218108 @default.
• W2091917308 cites W2071008387 @default.
• W2091917308 cites W2073809562 @default.
• W2091917308 cites W2077954177 @default.
• W2091917308 cites W2083886218 @default.
• W2091917308 cites W2088662606 @default.
• W2091917308 cites W2096790349 @default.
• W2091917308 cites W2098601666 @default.
• W2091917308 cites W2109219174 @default.
• W2091917308 cites W2125756592 @default.
• W2091917308 cites W2129023980 @default.
• W2091917308 cites W2130889658 @default.
• W2091917308 cites W2134466112 @default.
• W2091917308 cites W2200068163 @default.
• W2091917308 cites W2253202562 @default.
• W2091917308 cites W2412168533 @default.
• W2091917308 cites W2614575602 @default.
• W2091917308 cites W59578793 @default.
• W2091917308 doi "https://doi.org/10.1086/321262" @default.
• W2091917308 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1226051" @default.
• W2091917308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11391481" @default.
• W2091917308 hasPublicationYear "2001" @default.
• W2091917308 type Work @default.
• W2091917308 sameAs 2091917308 @default.
• W2091917308 citedByCount "219" @default.
• W2091917308 countsByYear W20919173082012 @default.
• W2091917308 countsByYear W20919173082013 @default.
• W2091917308 countsByYear W20919173082014 @default.
• W2091917308 countsByYear W20919173082015 @default.
• W2091917308 countsByYear W20919173082016 @default.
• W2091917308 countsByYear W20919173082017 @default.
• W2091917308 countsByYear W20919173082018 @default.
• W2091917308 countsByYear W20919173082019 @default.
• W2091917308 countsByYear W20919173082020 @default.
• W2091917308 countsByYear W20919173082021 @default.
• W2091917308 countsByYear W20919173082022 @default.
• W2091917308 countsByYear W20919173082023 @default.
• W2091917308 crossrefType "journal-article" @default.
• W2091917308 hasAuthorship W2091917308A5001010319 @default.
• W2091917308 hasAuthorship W2091917308A5024927199 @default.
• W2091917308 hasAuthorship W2091917308A5037379883 @default.
• W2091917308 hasAuthorship W2091917308A5062637673 @default.
• W2091917308 hasAuthorship W2091917308A5080241543 @default.
• W2091917308 hasAuthorship W2091917308A5090458735 @default.
• W2091917308 hasBestOaLocation W20919173081 @default.
• W2091917308 hasConcept C104317684 @default.
• W2091917308 hasConcept C126322002 @default.
• W2091917308 hasConcept C134018914 @default.
• W2091917308 hasConcept C137555145 @default.
• W2091917308 hasConcept C16525657 @default.
• W2091917308 hasConcept C2776229224 @default.
• W2091917308 hasConcept C2777090595 @default.
• W2091917308 hasConcept C2780912031 @default.
• W2091917308 hasConcept C30481170 @default.
• W2091917308 hasConcept C515207424 @default.
• W2091917308 hasConcept C54355233 @default.
• W2091917308 hasConcept C55493867 @default.
• W2091917308 hasConcept C71924100 @default.
• W2091917308 hasConcept C80315684 @default.
• W2091917308 hasConcept C86803240 @default.
• W2091917308 hasConceptScore W2091917308C104317684 @default.
• W2091917308 hasConceptScore W2091917308C126322002 @default.
• W2091917308 hasConceptScore W2091917308C134018914 @default.
• W2091917308 hasConceptScore W2091917308C137555145 @default.
• W2091917308 hasConceptScore W2091917308C16525657 @default.
• W2091917308 hasConceptScore W2091917308C2776229224 @default.
• W2091917308 hasConceptScore W2091917308C2777090595 @default.
• W2091917308 hasConceptScore W2091917308C2780912031 @default.
• W2091917308 hasConceptScore W2091917308C30481170 @default.
• W2091917308 hasConceptScore W2091917308C515207424 @default.

• next